Home / Pharma Products for Licensing & Distribution Rights /

Pharma Products for Licensing & Distribution Rights

Listings of generic and innovative medicines with MA/MAH licensing, dossier access, and optional CDMO manufacturing for global markets.

You have not added any products for licensing.
Add your portfolio to be contacted by potential partners.

Explore pharma products for licensing and distribution

The demand for pharma products for licensing continues to grow as companies seek faster ways to expand portfolios, secure distribution rights, and accelerate entry into regulated markets. MAI CDMO Network offers a searchable pharmaceutical product list where every record includes the essential fields: product name, strength, dosage form, market, and offer type. This structure allows portfolio managers, distributors, and business development teams to easily find opportunities for in-licensing, MA/MAH licensing, dossier licensing, and CDMO manufacturing.

Searchable product data

The system is designed to give buyers clear and actionable information:

Product name + strength + dosage form: for example, “Amoxicillin 500 mg tablets” or “Atorvastatin 20 mg capsules.”
Market: a dropdown selector covering global regions and key countries.
Offer type: choose whether the listing is manufacturing only, distribution rights only, marketing authorization (MA), or combinations such as MA + Manufacturing and MA + Distribution rights.

Markets covered in detail

Licensing opportunities are not limited to one geography. MAI CDMO Network covers a broad spectrum of territories, allowing users to filter by region or key country:

Global: products available for worldwide licensing and distribution.
European Union (EU): suitable for centralized or decentralized EMA submissions.
European Economic Area (EEA): extending coverage beyond the EU to additional European markets.
North America (USA, Canada, Mexico): includes FDA and Health Canada compliant dossiers and distribution opportunities.
Latin America (LATAM): markets like Brazil, Argentina, and Mexico with growing demand for generic drugs for licensing.
Middle East & North Africa (MENA): regional authorizations and distribution rights adapted to local agencies.
Sub-Saharan Africa: diverse opportunities for essential medicines and ready-to-license pharmaceuticals.
Asia-Pacific (APAC): fast-growing markets such as China, India, Japan, and Australia.
CIS countries: including Russia and neighboring markets with specific regulatory frameworks.

Key individual markets are also listed for more precise targeting: United States, Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Italy, Spain, China, India, Japan, and Australia. This granularity makes it possible to match pharmaceutical licensing opportunities to your exact territory needs.

Types of offers available

Each listing specifies the offer type so you can identify what is on the table:

Manufacturing only: contract manufacturing without licensing or distribution rights.
Distribution rights only: commercial rights to sell in defined territories.
Marketing Authorisation (MA): access to an existing MA or the ability to license it.
Manufacturing + Distribution rights: supply plus sales authorization in chosen markets.
MA + Manufacturing: licensing of the authorization combined with production rights.
MA + Manufacturing + Distribution rights: a complete package including regulatory, supply, and commercialization.

This transparent categorization helps companies quickly evaluate whether a product is aligned with their business model, whether that means sourcing from a CDMO, obtaining distribution rights, or acquiring marketing authorization licensing.

Benefits for different users

The MAI CDMO Network licensing catalog is designed for:

Pharma companies: to expand their pipeline with in-licensed assets and accelerate market entry.
Distributors: to secure distribution rights in their regions with minimal lead time.
CDMOs and manufacturers: to showcase products where they can provide manufacturing services.
Startups and smaller firms: to use dossier licensing plus CDMO manufacturing for quick launches.

Why use MAI CDMO Network

By consolidating pharma products for licensing into one searchable database, MAI CDMO Network reduces the time and complexity of identifying new opportunities. The structure — product name, strength, dosage form, market, and offer type — provides clarity and comparability. Whether you are seeking MA/MAH licensing, dossier licensing, or distribution rights, the platform makes it simple to find, filter, and connect with the right partner. With global coverage spanning EU, EEA, North America, LATAM, MENA, Sub-Saharan Africa, APAC, CIS, and key countries such as US, UK, Germany, China, India, Japan and more, this catalog is your gateway to ready-to-license pharmaceuticals worldwide.

Get started today

Use MAI CDMO Network to search for pharma products for licensing by product name, strength, dosage form, target market, and offer type. Explore opportunities across EMA, FDA and other regulatory territories, and find the right mix of manufacturing, distribution rights, and MA/MAH licensing to expand your business.

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.